Five UWSOP faculty and alumni have led ISPOR over the past 20 years
UW School of Pharmacy faculty and alumni are again recognized as leaders in health care. The International Society for Pharmacoeconomics and Outcomes Research (ISPOR) announced the election of the Society’s 2016-2017 Board of Directors that assumed office on July 1, 2016. Many of the new leadership team are part of the UW School of Pharmacy family. This recent election marks an historic time when UW School of Pharmacy is represented in the past, current and future presidential leadership roster for ISPOR, showcasing our outstanding alumni and preeminent faculty.
Lou Garrison, PhD, assumes the role of President for 2016-17 after most recently serving as the Society’s President-Elect. Lou is a highly-respected Professor in the Pharmaceutical Outcomes Research and Policy Program in UWSOP. “I am honored and privileged to have the opportunity to serve as President of ISPOR this coming year as we enter our third decade. My priorities will be: supporting our global network to expand capacity in outcomes research, continuing to improve the science of outcomes research through our task forces and journals, and collaborating with allied organizations, such as ASHEcon, HTAi, AMCP, DIA, SMDM, and AcademyHealth.”
Daniel C. Malone, RPh, PhD, who had completed his post doc work at UWSOP, becomes Immediate Past President. Dan serves as Professor of Pharmacy, College of Pharmacy and Associate Professor in Mel and Enid Zuckerman College, University of Arizona in Tucson, Arizona.
ISPOR’s global membership elected Shelby D. Reed, RPh, PhD, who had also completed her post doc work here at UWSOP, to serve as President-Elect for the Society for 2016-17. Shelby is Professor, Duke University in Durham, North Carolina. Shelby’s election With Shelby’s election as ISPOR President-elect, UW School of Pharmacy has five faculty and alumni who have gone on to serve as President of ISPOR.
The new ISPOR Board of Directors also now includes alumnus John Watkins, MPH, PharmD, ’79, ’11, Formulary Manager, Premera Blue Cross in Mountlake Terrace, Washington. John received the UWSOP’s Award for Excellence in Clinical Teaching in 2014 for being an exemplary practitioner, role model, coach, facilitator, and team player for over 20 years.
ISPOR is an organization with tremendous influence in global health economics. In the words of our own Lou Garrison: ISPOR has “over 20,000 members in some 120 countries. When you absorb that fact, you realize that ISPOR as an organization has tremendous potential to have a positive impact on health globally—and not just by sheer numbers but also by the quality of our science. The medical product and decision processes that ISPOR members study are based on information—about how a molecule affects the body or about how well an health technology assessment process works—and this knowledge is a global public good, potentially benefitting 7 billion people on the planet.”
ISPOR’s Board of Directors are elected by its global membership. The International Society for Pharmacoeconomics and Outcomes Research (ISPOR) is a nonprofit, international, educational and scientific organization that promotes health economics and outcomes research excellence to improve decision making for health globally.